1. Home
  2. TMDX vs MAIN Comparison

TMDX vs MAIN Comparison

Compare TMDX & MAIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TransMedics Group Inc.

TMDX

TransMedics Group Inc.

HOLD

Current Price

$99.21

Market Cap

4.6B

Sector

Health Care

ML Signal

HOLD

Logo Main Street Capital Corporation

MAIN

Main Street Capital Corporation

HOLD

Current Price

$51.57

Market Cap

5.3B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
TMDX
MAIN
Founded
1998
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
4.6B
5.3B
IPO Year
2019
2013

Fundamental Metrics

Financial Performance
Metric
TMDX
MAIN
Price
$99.21
$51.57
Analyst Decision
Buy
Hold
Analyst Count
9
7
Target Price
$154.00
$61.57
AVG Volume (30 Days)
923.9K
832.0K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
8.16%
EPS Growth
382.18
N/A
EPS
4.87
3.95
Revenue
$605,494,000.00
N/A
Revenue This Year
$24.51
$6.27
Revenue Next Year
$18.73
$5.14
P/E Ratio
$20.97
$13.39
Revenue Growth
37.13
N/A
52 Week Low
$62.42
$47.00
52 Week High
$156.00
$67.77

Technical Indicators

Market Signals
Indicator
TMDX
MAIN
Relative Strength Index (RSI) 24.72 26.68
Support Level N/A N/A
Resistance Level $131.86 $59.24
Average True Range (ATR) 5.48 1.36
MACD -2.58 -0.22
Stochastic Oscillator 3.82 2.37

Price Performance

Historical Comparison
TMDX
MAIN

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About MAIN Main Street Capital Corporation

Main Street Capital Corp is an investment firm engaged in providing customized debt and equity financing to lower middle market companies and debt capital to middle market companies. The investment portfolio of the company is typically made to support management buyouts, recapitalizations, growth financings, refinancing, and acquisitions of companies that operate in diverse industry sectors. The group invests in secured debt investments, equity investments, warrants, and other securities of the lower middle market and middle market companies based in the United States. Business functioned through the U.S. region and it derives the majority of its income from the source of fees, commission, and interest.

Share on Social Networks: